Brief: Opsens Successfully Completes 20-Patient In Study For TAVR Procedure
23/11/2021 12:02
Nov 23 (Reuters) - Opsens Inc OPS.TO :
* OPSENS SUCCESSFULLY COMPLETES 20-PATIENT IN HUMAN CLINICAL
STUDY
FOR TAVR PROCEDURE
Source text for Eikon: ID:nCNWMFG1ma
Further company coverage: OPS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe